FDA Announces Collection of Information for Office of Management and Budget Review

Summary

The Food and Drug Administration (FDA) has submitted a proposed collection of information to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995, as part of a comment request and focus groups about drug products used by the FDA.